ARCHIVES

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

This article is from The Cancer Letter archive.

Vol. 05 No. 43 | October 26, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

DeVita Reshuffling NCI Office Space

April 18, 1980

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980